Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| SEER Program | 7 | 2020 | 1508 | 1.470 |
Why?
|
| Neoplasms, Second Primary | 4 | 2019 | 1061 | 1.470 |
Why?
|
| Sarcoma, Kaposi | 2 | 2019 | 370 | 1.020 |
Why?
|
| Quality-Adjusted Life Years | 5 | 2022 | 1683 | 0.750 |
Why?
|
| Carcinoma, Transitional Cell | 6 | 2022 | 808 | 0.740 |
Why?
|
| Wasting Syndrome | 1 | 2020 | 101 | 0.690 |
Why?
|
| Radiodermatitis | 1 | 2019 | 60 | 0.690 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2018 | 61 | 0.650 |
Why?
|
| Developing Countries | 2 | 2020 | 2815 | 0.610 |
Why?
|
| Genital Diseases, Male | 1 | 2017 | 84 | 0.580 |
Why?
|
| Thymoma | 1 | 2018 | 186 | 0.570 |
Why?
|
| Scrotum | 1 | 2017 | 115 | 0.570 |
Why?
|
| Ciprofloxacin | 1 | 2018 | 315 | 0.570 |
Why?
|
| Anilides | 1 | 2019 | 408 | 0.550 |
Why?
|
| Fluid Therapy | 1 | 2020 | 593 | 0.550 |
Why?
|
| Hyponatremia | 1 | 2018 | 298 | 0.530 |
Why?
|
| Fibroma | 1 | 2016 | 212 | 0.510 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2022 | 2245 | 0.500 |
Why?
|
| Patient Care | 1 | 2020 | 640 | 0.470 |
Why?
|
| Multiple Myeloma | 3 | 2020 | 5181 | 0.470 |
Why?
|
| Diarrhea | 2 | 2020 | 1348 | 0.470 |
Why?
|
| Testis | 1 | 2017 | 803 | 0.460 |
Why?
|
| Heart Neoplasms | 1 | 2016 | 374 | 0.450 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 788 | 0.420 |
Why?
|
| Hematoma | 1 | 2017 | 758 | 0.410 |
Why?
|
| Overweight | 2 | 2020 | 2371 | 0.410 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 1018 | 0.400 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6773 | 0.380 |
Why?
|
| Hodgkin Disease | 1 | 2018 | 1415 | 0.360 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 1333 | 0.360 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1583 | 0.360 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2017 | 1381 | 0.360 |
Why?
|
| Radiosurgery | 1 | 2019 | 1329 | 0.350 |
Why?
|
| Lymphocytes | 1 | 2017 | 2617 | 0.340 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.340 |
Why?
|
| Risk Assessment | 3 | 2019 | 23338 | 0.340 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 1873 | 0.330 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1596 | 0.320 |
Why?
|
| Poverty | 1 | 2020 | 2660 | 0.320 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 3158 | 0.310 |
Why?
|
| Survivors | 1 | 2018 | 2291 | 0.310 |
Why?
|
| Pyridines | 1 | 2019 | 2825 | 0.300 |
Why?
|
| Registries | 2 | 2019 | 8089 | 0.290 |
Why?
|
| Aortic Valve | 1 | 2016 | 1922 | 0.280 |
Why?
|
| Patient Readmission | 1 | 2020 | 3114 | 0.270 |
Why?
|
| Carcinoma | 1 | 2017 | 2375 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 4034 | 0.240 |
Why?
|
| Middle Aged | 20 | 2022 | 213383 | 0.230 |
Why?
|
| Risk Factors | 8 | 2022 | 72290 | 0.220 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 57776 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 6364 | 0.210 |
Why?
|
| Humans | 39 | 2022 | 744343 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5256 | 0.200 |
Why?
|
| HIV Infections | 2 | 2019 | 16718 | 0.200 |
Why?
|
| Male | 22 | 2021 | 350118 | 0.200 |
Why?
|
| United States | 9 | 2020 | 69872 | 0.190 |
Why?
|
| Incidence | 7 | 2022 | 20947 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.180 |
Why?
|
| Female | 22 | 2021 | 380194 | 0.180 |
Why?
|
| Adult | 16 | 2022 | 214055 | 0.180 |
Why?
|
| Mass Screening | 1 | 2015 | 5255 | 0.180 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.170 |
Why?
|
| Arrhythmia, Sinus | 1 | 2018 | 56 | 0.170 |
Why?
|
| Lung | 1 | 2017 | 9856 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5221 | 0.160 |
Why?
|
| Geography | 1 | 2020 | 669 | 0.160 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 683 | 0.150 |
Why?
|
| Aged | 13 | 2021 | 163280 | 0.150 |
Why?
|
| Morbidity | 2 | 2020 | 1769 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2019 | 711 | 0.150 |
Why?
|
| Hereditary Angioedema Types I and II | 1 | 2016 | 10 | 0.150 |
Why?
|
| Urologic Neoplasms | 1 | 2021 | 318 | 0.140 |
Why?
|
| Angioedema | 1 | 2018 | 187 | 0.140 |
Why?
|
| Bradycardia | 1 | 2018 | 307 | 0.140 |
Why?
|
| Abdomen, Acute | 1 | 2016 | 123 | 0.140 |
Why?
|
| Young Adult | 8 | 2020 | 56430 | 0.140 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2018 | 245 | 0.130 |
Why?
|
| Retrospective Studies | 13 | 2022 | 77449 | 0.130 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 3086 | 0.130 |
Why?
|
| Demography | 1 | 2020 | 1656 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 458 | 0.130 |
Why?
|
| Neck | 1 | 2019 | 697 | 0.120 |
Why?
|
| Glucosides | 1 | 2018 | 451 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1788 | 0.120 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2018 | 233 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13695 | 0.120 |
Why?
|
| Medically Uninsured | 1 | 2020 | 853 | 0.120 |
Why?
|
| Stroke | 1 | 2016 | 9981 | 0.120 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 652 | 0.120 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 379 | 0.110 |
Why?
|
| Malnutrition | 1 | 2020 | 625 | 0.110 |
Why?
|
| Sodium | 1 | 2018 | 1623 | 0.110 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 782 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2020 | 2453 | 0.110 |
Why?
|
| Air Pollution, Indoor | 1 | 2020 | 857 | 0.110 |
Why?
|
| Kidney Neoplasms | 2 | 2020 | 4262 | 0.110 |
Why?
|
| Tetrazoles | 1 | 2018 | 835 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.110 |
Why?
|
| Heparin | 1 | 2020 | 1637 | 0.110 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 845 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 924 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6538 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2309 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 1179 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2020 | 1609 | 0.100 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 2924 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13102 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 12354 | 0.100 |
Why?
|
| Income | 1 | 2020 | 1913 | 0.100 |
Why?
|
| Social Class | 1 | 2020 | 1999 | 0.100 |
Why?
|
| Lymphoma | 1 | 2020 | 1877 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3479 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2020 | 25625 | 0.090 |
Why?
|
| Infant | 3 | 2020 | 35136 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 1199 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2020 | 41006 | 0.080 |
Why?
|
| Acute Disease | 1 | 2020 | 7149 | 0.080 |
Why?
|
| Cause of Death | 1 | 2019 | 3584 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3474 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 2400 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2020 | 2494 | 0.070 |
Why?
|
| Survival Rate | 2 | 2019 | 12788 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 3966 | 0.070 |
Why?
|
| Risk | 1 | 2019 | 9687 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11031 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2020 | 4397 | 0.070 |
Why?
|
| Length of Stay | 1 | 2020 | 6309 | 0.070 |
Why?
|
| Medicaid | 1 | 2020 | 2736 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4253 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2020 | 3209 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 18370 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5317 | 0.070 |
Why?
|
| Prevalence | 2 | 2020 | 15226 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12245 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7785 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2020 | 5102 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2019 | 7729 | 0.060 |
Why?
|
| Palliative Care | 1 | 2019 | 3493 | 0.060 |
Why?
|
| Prognosis | 3 | 2021 | 29063 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 3143 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2018 | 6150 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9239 | 0.060 |
Why?
|
| Adolescent | 3 | 2020 | 85781 | 0.060 |
Why?
|
| Administration, Intravesical | 1 | 2021 | 91 | 0.050 |
Why?
|
| Diet | 1 | 2020 | 7939 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39050 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2021 | 369 | 0.040 |
Why?
|
| Smoking | 1 | 2015 | 8987 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2019 | 356 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2022 | 63114 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2021 | 1000 | 0.030 |
Why?
|
| Complement C4 | 1 | 2016 | 257 | 0.030 |
Why?
|
| Platelet Count | 1 | 2018 | 781 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 551 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 53288 | 0.030 |
Why?
|
| Child | 2 | 2020 | 77709 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 11725 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2022 | 40561 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 10900 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 913 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2020 | 1184 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2018 | 1959 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2020 | 2740 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1518 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 522 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 21683 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 1364 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2019 | 1212 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2020 | 2616 | 0.020 |
Why?
|
| Heart Rate | 1 | 2018 | 4091 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2018 | 6442 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2018 | 6256 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11366 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 17446 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9648 | 0.010 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_